文献速递呼吸衰竭与机械通气心脑血管急症

多中心实施新型管理方案提高肺栓塞和深静脉血栓门诊治疗率

Multicenter Implementation of a Novel Management Protocol Increases the Outpatient Treatment of Pulmonary Embolism and Deep Vein Thrombosis.
PubMed 文献 · Acad Emerg Med · 2018-11-29
一句话结论多中心研究显示,风险分层联合利伐沙班治疗及明确随访的方案与更多静脉血栓栓塞症患者门诊治疗相关,且不良结局未增加。

该多中心研究在两家城市急诊科开展,纳入影像学确诊的急性静脉血栓栓塞症(肺栓塞或深静脉血栓)患者,比较方案实施前18个月与实施后18个月门诊治疗比例。方案结合风险分层、直接口服抗凝药利伐沙班治疗和明确随访。实施后静脉血栓栓塞症门诊治疗比例从26%升至35%,肺栓塞从12%升至18%,低风险肺栓塞从18%升至28%,深静脉血栓从49%升至60%。死亡率、出血和急诊返诊罕见且未增加。

要点

  • 实施风险分层、利伐沙班和明确随访方案后,静脉血栓栓塞症门诊治疗比例从26%升至35%(p<0.001)。
  • 肺栓塞门诊治疗比例从12%升至18%(p=0.002),低风险肺栓塞从18%升至28%(p<0.001)。
  • 深静脉血栓门诊治疗比例从49%升至60%(p=0.002)。
  • 方案实施后7天和30天死亡率、大出血及急诊返诊罕见且未增加。

适用人群与场景

  • 两家城市急诊科中影像学确诊的急性静脉血栓栓塞症(肺栓塞或深静脉血栓)患者。
  • 研究纳入方案实施前18个月和实施后18个月的患者,方案前后人群平均年龄(59岁 vs 60岁)、女性比例(49% vs 49%)、其他人口学特征、合并疾病和肺栓塞风险分层相似。

处置流程与药物剂量

  • 方案结合风险分层、直接口服抗凝药利伐沙班治疗和明确随访。
  • 符合条件患者从急诊科或观察室出院,不收入院。

研究设计与关键结果

  • 多中心研究纳入2212例患者,方案前1081例(49%),方案后1131例(51%)。
  • 主要结局为静脉血栓栓塞症患者从急诊科或观察室出院(即未收入院)的比例。
  • 方案实施后静脉血栓栓塞症门诊治疗比例从26%升至35%(p<0.001)。
  • 方案实施后肺栓塞门诊治疗比例从12%升至18%(p=0.002)。
  • 方案实施后低风险肺栓塞门诊治疗比例从18%升至28%(p<0.001)。
  • 方案实施后深静脉血栓门诊治疗比例从49%升至60%(p=0.002)。
  • 方案实施后7天和30天死亡率、大出血和急诊返诊罕见且未增加。

证据类型、等级与局限

  • 证据类型:多中心研究(方案实施前后比较)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,结合风险分层、利伐沙班治疗和明确随访的方案与更多肺栓塞和深静脉血栓患者门诊治疗相关,且不良结局未增加。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: The objective was to determine whether a protocol combining risk stratification, treatment with the direct-acting oral anticoagulant rivaroxaban, and defined follow-up is associated with a greater proportion of patients with venous thromboembolism (VTE) treated as outpatients, without hospital admission.

METHODS: We performed a multicenter study of patients diagnosed with VTE (pulmonary embolism [PE] or deep vein thrombosis [DVT]) in two urban EDs, 18 months before and 18 months after implementation of an outpatient VTE treatment protocol. Patients with radiographically confirmed acute VTE were eligible. Our primary outcome was the proportion of VTE patients discharged from the ED or observation unit (i.e., without hospital admission). We performed subgroup analyses according to hospital, DVT and PE, and low-risk PE. We also assessed 7- and 30-day mortality, major bleeding, and returns to the ED. We compared proportions using chi-square and Fisher's exact tests.

RESULTS: We enrolled 2,212 patients, 1,081 (49%) before protocol and 1,131 (51%) after protocol. Mean age (59 years vs. 60 years), female sex (49% vs. 49%), other demographics, comorbid illness, and PE risk stratification were similar before and after. After protocol, more VTE (35% from 26%, p < 0.001), PE (18% from 12%, p = 0.002), low-risk PE (28% from 18%, p < 0.001), and DVT (60% from 49%, p = 0.002) patients were treated as outpatients. Mortality, bleeding, and returns to ED were rare and did not increase after protocol.

CONCLUSIONS: A treatment protocol combining risk-stratification, rivaroxaban treatment and defined follow-up is associated with an increase in PE and DVT patients treated as outpatients, with no increase in adverse outcomes.

来源:Acad Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Kabrhel C, Rosovsky R, Baugh C, et al. Multicenter Implementation of a Novel Management Protocol Increases the Outpatient Treatment of Pulmonary Embolism and Deep Vein Thrombosis. Acad Emerg Med. 2018. PMID: 30341928. doi:10.1111/acem.13640

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。